Follow
Zheng Zhang
Zheng Zhang
Research Center for Biological Therapy, Beijing 302 Hospital, Beijing, China
Verified email at moon.ibp.ac.cn
Title
Cited by
Cited by
Year
Antibody responses to SARS-CoV-2 in patients with novel coronavirus disease 2019
J Zhao, Q Yuan, H Wang, W Liu, X Liao, Y Su, X Wang, J Yuan, T Li, J Li, ...
Clinical infectious diseases 71 (16), 2027-2034, 2020
29122020
Treatment of 5 critically ill patients with COVID-19 with convalescent plasma
C Shen, Z Wang, F Zhao, Y Yang, J Li, J Yuan, F Wang, D Li, M Yang, ...
Jama 323 (16), 1582-1589, 2020
25682020
Genome composition and divergence of the novel coronavirus (2019-nCoV) originating in China
A Wu, Y Peng, B Huang, X Ding, X Wang, P Niu, J Meng, Z Zhu, Z Zhang, ...
Cell host & microbe 27 (3), 325-328, 2020
22682020
Clinical and biochemical indexes from 2019-nCoV infected patients linked to viral loads and lung injury
Y Liu, Y Yang, C Zhang, F Huang, F Wang, J Yuan, Z Wang, J Li, J Li, ...
Science China Life Sciences 63 (3), 364-374, 2020
19972020
Single-cell landscape of bronchoalveolar immune cells in patients with COVID-19
M Liao, Y Liu, J Yuan, Y Wen, G Xu, J Zhao, L Cheng, J Li, X Wang, ...
Nature medicine 26 (6), 842-844, 2020
16412020
Human neutralizing antibodies elicited by SARS-CoV-2 infection
B Ju, Q Zhang, J Ge, R Wang, J Sun, X Ge, J Yu, S Shan, B Zhou, S Song, ...
Nature 584 (7819), 115-119, 2020
14472020
Experimental treatment with favipiravir for COVID-19: an open-label control study
Q Cai, M Yang, D Liu, J Chen, D Shu, J Xia, X Liao, Y Gu, Q Cai, Y Yang, ...
Engineering 6 (10), 1192-1198, 2020
13152020
The global burden of liver disease: the major impact of China
FS Wang, JG Fan, Z Zhang, B Gao, HY Wang
Hepatology 60 (6), 2099-2108, 2014
12012014
Community transmission of severe acute respiratory syndrome coronavirus 2, Shenzhen, China, 2020
J Liu, X Liao, S Qian, J Yuan, F Wang, Y Liu, Z Wang, FS Wang, L Liu, ...
Emerging infectious diseases 26 (6), 1320, 2020
9102020
Increased regulatory T cells correlate with CD8 T-cell impairment and poor survival in hepatocellular carcinoma patients
J Fu, D Xu, Z Liu, M Shi, P Zhao, B Fu, Z Zhang, H Yang, H Zhang, C Zhou, ...
Gastroenterology 132 (7), 2328-2339, 2007
8772007
Evaluating the accuracy of different respiratory specimens in the laboratory diagnosis and monitoring the viral shedding of 2019-nCoV infections
Y Yang, M Yang, C Shen, F Wang, J Yuan, J Li, M Zhang, Z Wang, L Xing, ...
MedRxiv, 2020
8022020
Single cell RNA sequencing of 13 human tissues identify cell types and receptors of human coronaviruses
F Qi, S Qian, S Zhang, Z Zhang
Biochemical and biophysical research communications 526 (1), 135-140, 2020
7522020
Relationship between the ABO blood group and the coronavirus disease 2019 (COVID-19) susceptibility
J Zhao, Y Yang, H Huang, D Li, D Gu, X Lu, Z Zhang, L Liu, T Liu, Y Liu, ...
Clinical Infectious Diseases 73 (2), 328-331, 2021
7232021
SARS-CoV-2 invades host cells via a novel route: CD147-spike protein
K Wang, W Chen, YS Zhou, JQ Lian, Z Zhang, P Du, L Gong, Y Zhang, ...
biorxiv, 2020
6802020
Interleukin‐17–producing CD4+ T cells increase with severity of liver damage in patients with chronic hepatitis B
JY Zhang, Z Zhang, F Lin, ZS Zou, RN Xu, L Jin, JL Fu, F Shi, M Shi, ...
Hepatology 51 (1), 81-91, 2010
5582010
CD147-spike protein is a novel route for SARS-CoV-2 infection to host cells
KE Wang, W Chen, Z Zhang, Y Deng, JQ Lian, P Du, D Wei, Y Zhang, ...
Signal transduction and targeted therapy 5 (1), 1-10, 2020
5232020
Elevated calprotectin and abnormal myeloid cell subsets discriminate severe from mild COVID-19
A Silvin, N Chapuis, G Dunsmore, AG Goubet, A Dubuisson, L Derosa, ...
Cell 182 (6), 1401-1418. e18, 2020
5022020
Plasma IP-10 and MCP-3 levels are highly associated with disease severity and predict the progression of COVID-19
Y Yang, C Shen, J Li, J Yuan, J Wei, F Huang, F Wang, G Li, Y Li, L Xing, ...
Journal of Allergy and Clinical Immunology 146 (1), 119-127. e4, 2020
4942020
PD‐1 and PD‐L1 upregulation promotes CD8+ T‐cell apoptosis and postoperative recurrence in hepatocellular carcinoma patients
F Shi, M Shi, Z Zeng, RZ Qi, ZW Liu, JY Zhang, YP Yang, P Tien, FS Wang
International journal of cancer 128 (4), 887-896, 2011
4442011
Autologous cytokine-induced killer cell therapy in clinical trial phase I is safe in patients with primary hepatocellular carcinoma
M Shi, B Zhang, ZR Tang, ZY Lei, HF Wang, YY Feng, ZP Fan, DP Xu, ...
World journal of gastroenterology 10 (8), 1146, 2004
4362004
The system can't perform the operation now. Try again later.
Articles 1–20